ESC 365 - Determining Subcuteneous-ICD suitability: Predictors of appropriate antitachycardia pacing therapy.

EHRA Premium Access

Determining Subcuteneous-ICD suitability: Predictors of appropriate antitachycardia pacing therapy.

Session: Poster session 3 - Sudden cardiac death and implantable defibrillators

Topic: Secondary prevention (Sudden cardiac death and implantable defibrillators)

Speaker: Doctor A. Quast (Amsterdam, NL)

Event: EHRA EUROPACE - CARDIOSTIM 2017

Congress Presentation

Add to my library

About the speaker

Doctor Anne-Floor Barbara Eleonore Quast

Academic Medical Centre, Amsterdam (Netherlands (The))

0 follower

16 more presentations in this session

Long-term effectiveness and complications of ICDs in patients with hypertrophic cardiomyopathy

Speaker: Miss N. Calvo Galiano (Zaragoza, ES)

Prophylactic cardioverter-defibrillator implantation in systolic heart failure: does the aetiology of cardiomyopathy matter?

Speaker: Miss M. Braga (Porto, PT)

Performance of sudden cardiac death risk score at the time of device replacement for patients with hypertrophic cardiomyopathy

Speaker: Doctor M. Biffi (Bologna, IT)

Predictors of future implantable cardioverter-defibrillators appropriate therapies in patients undergoing generator replacement: who still benefiting from implantable cardioverter-defibrillators?

Speaker: Doctor M. Madeira (Coimbra, PT)

Prognosis of cardiac sarcoidosis in patients with implantable cardioverter defibrillator -primary versus secondary prevention-

Speaker: Doctor M. Nakano (Chiba, JP)

Access the full session

Poster session 3 - Sudden cardiac death and implantable defibrillators

Speakers: Doctor A. Quast, Miss N. Calvo Galiano, Miss M. Braga, Doctor M. Biffi, Doctor M. Madeira...

About the event

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources